Transcriptional Regulation of Wnt Inhibitory Factor-1 by Miz-1/c-Myc

Overview

Journal Oncogene

Specialties Molecular Biology
Oncology

Date 2010 Aug 11

PMID 20697356

Citations 18

Authors

J D F Licchesi

L Van Neste

V K Tiwari

L Cope

X Lin

S B Baylin

J G Herman

Affiliations

Soon will be listed here.

Abstract

The Wnt signaling pathway is capable of self-regulation through positive and negative feedback mechanisms. For example, the oncoprotein c-Myc, which is upregulated by Wnt signaling activity, participates in a positive feedback loop of canonical Wnt signaling through repression of Wnt antagonists DKK1 and SFRP1. In this study, we investigated the mechanism of Wnt inhibitory factor-1 (WIF-1) silencing. Mapping of CpG island methylation of the WIF-1 promoter reveals regional methylation (-295 to -95 bp from the transcription start site) that correlates with transcriptional silencing. We identified Miz-1 as a direct activator of WIF-1 transcriptional activity, which is found at WIF-1 promoter. In addition, we show that c-Myc contributes to WIF-1 transcriptional repression in a Miz-1-dependent manner. Although the transient repression mediated by Miz-1/c-Myc is independent of de novo methylation, the stable repression by this complex is associated with CpG island methylation of the critical -295 to -95-bp region of the WIF-1 promoter. Importantly, Miz-1 and c-Myc are found at WIF-1 promoter in WIF-1 non-expressing cell lines DLD-1 and 209myc. Transient knockdown or somatic knockout of c-Myc in DLD-1 failed to restore WIF-1 expression suggesting that c-Myc is involved in initiating rather than maintaining WIF-1 epigenetic silencing. In a genome-wide screen, DNAJA4, TGFβ-induced and TRIM59 were repressed by c-Myc overexpression and DNA promoter hypermethylation. Our data reveal novel insights into c-Myc-mediated DNA methylation-dependent transcriptional silencing, a mechanism that might contribute to the dysregulation of Wnt signaling in cancer.

Citing Articles

Epigenetic alterations induced by genotoxic occupational and environmental human chemical carcinogens: An update of a systematic literature review.

Goodman S, Chappell G, Guyton K, Pogribny I, Rusyn I Mutat Res Rev Mutat Res. 2022; 789:108408.

PMID: 35690411 PMC: 9188653. DOI: 10.1016/j.mrrev.2021.108408.

Recognition of DNA Methylation Molecular Features for Diagnosis and Prognosis in Gastric Cancer.

Liu D, Li L, Wang L, Wang C, Hu X, Jiang Q Front Genet. 2021; 12:758926.

PMID: 34745226 PMC: 8566671. DOI: 10.3389/fgene.2021.758926.

Targeting Myc Interacting Proteins as a Winding Path in Cancer Therapy.

Zhou Y, Gao X, Yuan M, Yang B, He Q, Cao J Front Pharmacol. 2021; 12:748852.

PMID: 34658888 PMC: 8511624. DOI: 10.3389/fphar.2021.748852.

Radiosensitizing effects of c‑myc gene knockdown‑induced G2/M phase arrest by intrinsic stimuli via the mitochondrial signaling pathway.

Fan Y, Jia X, Xie T, Zhu L, He F Oncol Rep. 2020; 44(6):2669-2677.

PMID: 33125136 PMC: 7640369. DOI: 10.3892/or.2020.7806.

DKK1 promotes hepatocellular carcinoma inflammation, migration and invasion: Implication of TGF-β1.

Fezza M, Moussa M, Aoun R, Haber R, Hilal G PLoS One. 2019; 14(9):e0223252.

PMID: 31568519 PMC: 6768474. DOI: 10.1371/journal.pone.0223252.

References

Shah J, Shao G, Hei T, Zhao Y . Methylation screening of the TGFBI promoter in human lung and prostate cancer by methylation-specific PCR. BMC Cancer. 2008; 8:284. PMC: 2572632. DOI: 10.1186/1471-2407-8-284. View

Schuebel K, Chen W, Cope L, Glockner S, Suzuki H, Yi J . Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet. 2007; 3(9):1709-23. PMC: 1988850. DOI: 10.1371/journal.pgen.0030157. View

Li H, Rauch T, Chen Z, Szabo P, Riggs A, Pfeifer G . The histone methyltransferase SETDB1 and the DNA methyltransferase DNMT3A interact directly and localize to promoters silenced in cancer cells. J Biol Chem. 2006; 281(28):19489-500. DOI: 10.1074/jbc.M513249200. View

Hsieh J, Kodjabachian L, Rebbert M, Rattner A, Smallwood P, Samos C . A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature. 1999; 398(6726):431-6. DOI: 10.1038/18899. View

Zinn R, Pruitt K, Eguchi S, Baylin S, Herman J . hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site. Cancer Res. 2007; 67(1):194-201. DOI: 10.1158/0008-5472.CAN-06-3396. View

Chan S, Cui Y, van Hasselt A, Li H, Srivastava G, Jin H . The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas. Lab Invest. 2007; 87(7):644-50. DOI: 10.1038/labinvest.3700547. View

Tiwari V, McGarvey K, Licchesi J, Ohm J, Herman J, Schubeler D . PcG proteins, DNA methylation, and gene repression by chromatin looping. PLoS Biol. 2008; 6(12):2911-27. PMC: 2592355. DOI: 10.1371/journal.pbio.0060306. View

Taniguchi H, Yamamoto H, Hirata T, Miyamoto N, Oki M, Nosho K . Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers. Oncogene. 2005; 24(53):7946-52. DOI: 10.1038/sj.onc.1208910. View

Licchesi J, Westra W, Hooker C, Machida E, Baylin S, Herman J . Epigenetic alteration of Wnt pathway antagonists in progressive glandular neoplasia of the lung. Carcinogenesis. 2008; 29(5):895-904. PMC: 3312609. DOI: 10.1093/carcin/bgn017. View

10.

Wu S, Cetinkaya C, Munoz-Alonso M, von der Lehr N, Bahram F, Beuger V . Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter. Oncogene. 2003; 22(3):351-60. DOI: 10.1038/sj.onc.1206145. View

11.

He T, Sparks A, Rago C, Hermeking H, Zawel L, DA COSTA L . Identification of c-MYC as a target of the APC pathway. Science. 1998; 281(5382):1509-12. DOI: 10.1126/science.281.5382.1509. View

12.

Chen Z, Mann J, Hsieh C, Riggs A, Chedin F . Physical and functional interactions between the human DNMT3L protein and members of the de novo methyltransferase family. J Cell Biochem. 2005; 95(5):902-17. DOI: 10.1002/jcb.20447. View

13.

Gartel A, Ye X, Goufman E, Shianov P, Hay N, Najmabadi F . Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3. Proc Natl Acad Sci U S A. 2001; 98(8):4510-5. PMC: 31865. DOI: 10.1073/pnas.081074898. View

14.

Ahmed A, Mills A, Ibrahim A, Temple J, Blenkiron C, Vias M . The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel. Cancer Cell. 2007; 12(6):514-27. PMC: 2148463. DOI: 10.1016/j.ccr.2007.11.014. View

15.

Ai L, Tao Q, Zhong S, Fields C, Kim W, Lee M . Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer. Carcinogenesis. 2006; 27(7):1341-8. DOI: 10.1093/carcin/bgi379. View

16.

Osborne C, Chakalova L, Mitchell J, Horton A, Wood A, Bolland D . Myc dynamically and preferentially relocates to a transcription factory occupied by Igh. PLoS Biol. 2007; 5(8):e192. PMC: 1945077. DOI: 10.1371/journal.pbio.0050192. View

17.

Rhee I, Bachman K, Park B, Jair K, Yen R, Schuebel K . DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature. 2002; 416(6880):552-6. DOI: 10.1038/416552a. View

18.

Bowen H, Biggs T, Phillips E, Baker S, Perry V, Mann D . c-Myc represses and Miz-1 activates the murine natural resistance-associated protein 1 promoter. J Biol Chem. 2002; 277(38):34997-5006. DOI: 10.1074/jbc.M204232200. View

19.

Cowling V, DCruz C, Chodosh L, Cole M . c-Myc transforms human mammary epithelial cells through repression of the Wnt inhibitors DKK1 and SFRP1. Mol Cell Biol. 2007; 27(14):5135-46. PMC: 1951955. DOI: 10.1128/MCB.02282-06. View

20.

van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A . The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell. 2002; 111(2):241-50. DOI: 10.1016/s0092-8674(02)01014-0. View